GlassScriptPhysician profile
Gokhan Kilic
NPI 1366527392
$5,526.68
in general payments reported to CMS, 2019-2025
12 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $75.16 · 2021: $174 · 2022: $812 · 2023: $2,965 · 2024: $823 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,819 · Travel and Lodging: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,818.59 |
| Travel and Lodging | $1,369.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,403.91 | 2022-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $1,851.55 | 2019-2025 | Solyx Sis System, Advantage System, Axonics |
| Coopersurgical, INC. | $432.96 | 2021-2024 | Advincula Delineator Uterine Manipulator, Wallach Cryosurgical Equipment |
| Medtronic, INC. | $309.13 | 2021-2025 | Endo Stitch, Interstim |
| Astellas Pharma US INC | $119.55 | 2022 | |
| Coloplast Corp | $103.92 | 2020-2025 | |
| Intuitive Surgical, INC. | $82.92 | 2019 | |
| Medtronic USA, INC. | $68.48 | 2019-2020 | |
| Conmed Corporation | $62.50 | 2019 | |
| Sumitomo Pharma America, INC. | $39.45 | 2023-2024 | Gemtesa |
| Baxter Healthcare | $31.35 | 2025 | Tisseel |
| Abbvie INC. | $20.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gokhan Kilic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.